Available Single-Agent and Combination Therapies for mCSPC - Urology Times
7/19/2022 12:00:00 AM2 years 9 months ago
by Gordon A. Brown, DO
by Gordon A. Brown, DO
Dr Gordon Brown provides an overview of single-agent androgen deprivation therapy (ADT) and other regimens that may be used in combination with ADT, including androgen receptor (AR) inhibitors, for treatment of mCSPC.
Patient Profile: A 60-Year-Old-Man with Prostate Cancer Initial Presentation (Jan 2019) A 60-year-old man presented with urinary retention, fatigue, and decreased appetite No family history of pro… [+1434 chars]
full article...